HUTCHMED (China) (HCM) Long-Term Deferred Tax (2017 - 2025)
HUTCHMED (China) (HCM) posted quarterly Long-Term Deferred Tax of $12.7 million for Q4 2025, up 1.66% year-over-year from $12.4 million in Q4 2024, and up 1.66% quarter-over-quarter from $12.4 million in Q4 2024.
HUTCHMED (China) (HCM) Long-Term Deferred Tax (2017 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has reported Long-Term Deferred Tax for 9 consecutive years, with $12.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Long-Term Deferred Tax rose 1.66% year-over-year to $12.7 million; the TTM figure through Dec 2025 stood at $12.7 million (up 1.66% YoY), while the FY2025 annual figure was $12.7 million, up 1.66% from the prior year.
- Long-Term Deferred Tax rose to $12.7 million in Q4 2025 per HCM's latest filing, from $12.4 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $15.5 million in Q4 2023 and bottomed at $9.4 million in Q4 2021.
- Historically, Long-Term Deferred Tax has averaged $13.1 million across 5 years, with a median of $12.7 million in 2025.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax jumped 520.53% — and 2024, when it dropped 19.46%.
- HUTCHMED (China)'s Long-Term Deferred Tax stood at $9.4 million in 2021, then surged by 63.45% to $15.4 million in 2022, then gained by 0.59% to $15.5 million in 2023, then fell by 19.46% to $12.4 million in 2024, then increased by 1.66% to $12.7 million in 2025.
- Business Quant data shows HCM's Long-Term Deferred Tax at $12.7 million in Q4 2025, $12.4 million in Q4 2024, and $15.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 12.45 Mn |
| Dec 31, 2023 | 15.46 Mn |
| Dec 31, 2022 | 15.37 Mn |
| Dec 31, 2021 | 9.40 Mn |
| Dec 31, 2020 | 1.52 Mn |
| Dec 31, 2019 | 815,000.00 |
| Jun 30, 2019 | 7.51 Mn |
| Mar 31, 2019 | 1.39 Mn |
| Dec 31, 2018 | 580,000.00 |
| Jun 30, 2018 | 43.10 Mn |
| Dec 31, 2017 | 32.30 Mn |